| Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV A Stukalov, V Girault, V Grass, O Karayel, V Bergant, C Urban, DA Haas, ... Nature 594 (7862), 246-252, 2021 | 686 | 2021 |
| A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape P Hubel, C Urban, V Bergant, WM Schneider, B Knauer, A Stukalov, ... Nature immunology 20 (4), 493-502, 2019 | 176 | 2019 |
| Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs M Manček‐Keber, I Hafner‐Bratkovič, D Lainšček, M Benčina, T Govednik, ... The FASEB Journal 35 (6), 2021 | 52 | 2021 |
| Nuclear-localized human respiratory syncytial virus NS1 protein modulates host gene transcription J Pei, NR Beri, AJ Zou, P Hubel, HK Dorando, V Bergant, RD Andrews, ... Cell reports 37 (2), 2021 | 33 | 2021 |
| Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases V Bergant, S Yamada, V Grass, Y Tsukamoto, T Lavacca, K Krey, ... The EMBO journal 41 (17), e111608, 2022 | 27 | 2022 |
| The alternative cap-binding complex is required for antiviral defense in vivo A Gebhardt, V Bergant, D Schnepf, M Moser, A Meiler, D Togbe, ... PLoS pathogens 15 (12), e1008155, 2019 | 26 | 2019 |
| A nanoscaffolded spike-RBD vaccine provides protection against SARS-CoV-2 with minimal anti-scaffold response D Lainšček, T Fink, V Forstnerič, I Hafner-Bratkovič, S Orehek, Ž Strmšek, ... Vaccines 9 (5), 431, 2021 | 22 | 2021 |
| Influenza A virus infection reactivates human endogenous retroviruses associated with modulation of antiviral immunity H Liu, V Bergant, G Frishman, A Ruepp, A Pichlmair, M Vincendeau, ... Viruses 14 (7), 1591, 2022 | 12 | 2022 |
| mRNA 3’UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus V Bergant, D Schnepf, N de Andrade Krätzig, P Hubel, C Urban, ... Nature communications 14 (1), 4906, 2023 | 9 | 2023 |
| Multi-omics characterization of the monkeypox virus infection Y Huang, V Bergant, V Grass, Q Emslander, MS Hamad, P Hubel, ... Nature Communications 15 (1), 6778, 2024 | 8 | 2024 |
| Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv. 2020; 1: 1 A Stukalov, V Girault, V Grass, V Bergant, O Karayel, C Urban, DA Haas, ... Google Scholar, 0 | 5 | |
| Two Concomitant Polymorphs of Monomeric Nickel Acetate with 2-Pyridineethanol. M Trdin, V Bergant, I Leban, N Lah Acta Chimica Slovenica 59 (3), 2012 | 3 | 2012 |
| Engineered, nucleocytoplasmic shuttling Cas13d enables highly efficient cytosolic RNA targeting C Gruber, L Krautner, V Bergant, V Grass, Z Ma, L Rheinemann, A Krus, ... Cell Discovery 10 (1), 42, 2024 | 1 | 2024 |
| Epiblast morphogenesis is controlled by selective mRNA decay triggered by LIN28A relocation M Modic, IR de Los Mozos, S Steinhauser, E van Genderen, S Schirge, ... bioRxiv, 2021.03. 15.433780, 2021 | 1 | 2021 |
| Treatment of coronavirus infections using sam cycle inhibitors A Pichlmair, V Bergant, V Grass US Patent App. 18/280,325, 2024 | | 2024 |
| Data-driven host-directed antiviral drug repurposing against emerging pathogens V Bergant Technische Universität München, 2023 | | 2023 |
| Embryonic lumenogenesis is controlled by selective mRNA decay triggered by LIN28A relocation M Modic, IR Mozos, S Schirge, V Bergant, T Klobucar, C Mulholland, ... FEBS OPEN BIO 11, 334-335, 2021 | | 2021 |
| Epiblast morphogenesis is controlled by selective mRNA decay triggered by LIN28A relocation T Klobučar, E van Genderen, M Modic, R Faraway, H Lickert, ... (No Title), 2021 | | 2021 |
| Karakterizacija prisotnosti heterogenega jedrnega ribonukleoproteina H v citoplazemskih stresnih granulah: magistrsko delo V Bergant V. Bergant, 2016 | | 2016 |
| Poskus karakterizacije dveh cianobakterijskih inducibilnih promotorjev v Synechocystis PCC 6803 V Bergant V. Bergant, 2013 | | 2013 |
